1. Home
  2. Live Updates
  3. Biosimilar apis

Page 7 - Biosimilar Apis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosimilar apis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosimilar Apis Today - Breaking & Trending Today

Defining Interchangeability and Switching in Biologics

Medical experts discuss interchangeability designation requirements for biosimilars. ....

Ryan Haumschild , Bincy Abraham , Aliceb Gottlieb , Vibeke Strand , Reference Product , Cpt 13 ,

Initiating Biosimilar Treatment in Patients Without Previous Reference Biologic Experience

Vibeke Strand, MD, evaluates implementation of biosimilars in patients with no history of reference biologic use. ....

Ryan Haumschild , Bincy Abraham , Aliceb Gottlieb , Jamiet Brogan , Vibeke Strand , Reference Drug ,

Switching Patients from Reference Product to Biosimilar

Insight surrounding the switch from reference drugs to biosimilars is provided by Bincy Abraham, MD, MS. ....

Bincy Abraham , Ryan Haumschild , Aliceb Gottlieb , Vibeke Strand , Reference Drug ,

Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications

Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities. ....

United States , Rheinland Pfalz , Rituximab Rituxan , Bonniea Labdi , J Health Syst Pharm , Long Island University Pharmacy , Margolis Center , Duke University , Association For Accessible Medicines , Craneware Group , International Statistical Classification Of Diseases , Life Sciences , Trisus Medication Compare , International Statistical Classification , Tenth Revision , Appendix Table , Quarterly Utilization , Biosimilar Product , Deerfield Beach , Health Policy , Updated April , Manag Care Spec ,

Strong Results Observed for Adalimumab Biosimilar GP2017 for Inflammatory Bowel Disease

This study provides further support for the efficacy of this biosimilar, allowing for potential future reduction in costs for patients with IBD.
....

Cristina Bezzio , Gastroenterology Unit , Rho Hospital , Northern Italy , Turin Hospital , Adalimumab Biosimilar , Inflammatory Bowel , Among Biosimilars , Inflammatory Bowel Disease ,